Evidence map›Paper›PMID 23784730›Full record

ArticleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2013

Impact of the center on graft failure after liver transplantation.

Sumeet K Asrani, W Ray Kim, Erick B Edwards, Joseph J Larson, Gabriel Thabut, Walter K Kremers, Terry M Therneau, Julie Heimbach

Abstract read
In one paragraph

Article in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. FERI: A Multitask-based Fairness Achieving Algorithm with Applications to Fair Organ Transplantation.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Liver transplantation in Central Europe.Clinical and experimental hepatology · 2016
    Article
  12. Article
  13. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2015
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Development of organ-specific donor risk indices.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sumeet K AsraniDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MI; Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.
W Ray Kim
Erick B Edwards
Joseph J Larson
Gabriel Thabut
Walter K Kremers
Terry M Therneau
Julie Heimbach

Funding

MULTIDISCRIPLINARY TRAINING IN DIGESTIVE DISEASEST32DK007198 · NIDDK · MAYO CLINIC ROCHESTER · PI Harmeet Malhi · 1986 to 2026
$8.9M
Models for Optimal Liver Transplant OutcomesR01DK034238 · NIDDK · STANFORD UNIVERSITY · PI KIM, W. RAY · 1986 to 2015
$7.5M
Patient-oriented and effectiveness research in chronic liver diseaseK24DK092336 · NIDDK · STANFORD UNIVERSITY · PI KIM, W. RAY · 2012 to 2016
$627k
NIDDK NIH HHS K24 DK092336NIDDK NIH HHS R01 DK034238NIDDK NIH HHS R01DK-34238NIDDK NIH HHS T32 DK007198NIDDK NIH HHS T32 DK07198
6 · The paper itself

Abstract

The hospital at which liver transplantation (LT) is performed has a substantial impact on post-LT outcomes. Center-specific outcome data are closely monitored not only by the centers themselves but also by patients and government regulatory agencies. However, the true magnitude of this center effect, apart from the effects of the region and donor service area (DSA) as well as recipient and donor determinants of graft survival, has not been examined. We analyzed data submitted to the Organ Procurement and Transplantation Network for all adult (age ≥ 18 years) primary LT recipients (2005-2008). Using a mixed effects, proportional hazards regression analysis, we modeled graft failure within 1 year after LT on the basis of center (de-identified), region, DSA, and donor and recipient characteristics. At 115 unique centers, 14,654 recipients underwent transplantation. Rates of graft loss within a year varied from 5.9% for the lowest quartile of centers to 20.2% for the highest quartile. Gauged by a comparison of the 75th and 25th percentiles of the data, the magnitude of the center effect on graft survival (1.49-fold change) was similar to that of the recipient Model for End-Stage Liver Disease (MELD) score (1.47) and the donor risk index (DRI; 1.45). The center effect was similar across the DRI and MELD score quartiles and was not associated with a center's annual LT volume. After stratification by region and DSA, the magnitude of the center effect, though decreased, remained significant and substantial (1.30-fold interquartile difference). In conclusion, the LT center is a significant predictor of graft failure that is independent of region and DSA as well as donor and recipient characteristics.

Indexed as

Graft SurvivalHospitalsAdultFemaleGeographyHealth Status DisparitiesHumansLiver TransplantationMaleMiddle AgedOutcome Assessment, Health CareRegression AnalysisRiskSeverity of Illness IndexSurvival RateTime Factors

Identifiers

PMID23784730
PMCPMC4130473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.